Evidence map›Paper›PMID 38394178›Full record

ArticlePloS one2024

Strengthening laboratories in response to outbreaks in humanitarian emergencies and conflict settings: Results, challenges and lessons from expanding PCR diagnostic capacities for COVID-19 testing in Yemen.

Ismail Mahat Bashir, Ali Ahmed Al-Waleedi, Saeed Mohamed Al-Shaibani, Mohammed Rajamanar, Shougi Al-Akbari, Abdulelah Al-Harazi, Layla Salim Aliwah, Nahed Ahmed Salem, Dina Al-Ademi, Amal Barakat and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Ismail Mahat BashirWorld Health Organization, Sana'a, Yemen.ORCID 0000-0001-5614-2436
Ali Ahmed Al-WaleediMinistry of Public Health and Population, Aden, Yemen.
Saeed Mohamed Al-ShaibaniWorld Health Organization, Sana'a, Yemen.
Mohammed RajamanarWorld Health Organization, Sana'a, Yemen.
Shougi Al-AkbariMinistry of Public Health and Population, Aden, Yemen.
Abdulelah Al-HaraziNational Centre for Public Health Laboratories, Sanaa, Yemen.
Layla Salim AliwahNational Centre for Public Health Laboratories, Sanaa, Yemen.
Nahed Ahmed SalemNational Centre for Public Health Laboratories, Aden, Yemen.
Dina Al-AdemiWorld Health Organization, Sana'a, Yemen.
Amal BarakatWorld Health Organization, East Mediterranean Regional Office, Cairo, Egypt.
Nicole SarkisWorld Health Organization, Sana'a, Yemen.
Abdinasir AbubakarWorld Health Organization, East Mediterranean Regional Office, Cairo, Egypt.
Mikiko SengaWorld Health Organization, Sana'a, Yemen.
Altaf MusaniWorld Health Organization, Sana'a, Yemen.
Adham Rashad Ismail Abdel MoneimWorld Health Organization, Sana'a, Yemen.
Nuha MahmoudWorld Health Organization, Sana'a, Yemen.
Sana'a University · YEUniversity of Aden · YEWorld Health Organization Regional Office for the Eastern Mediterranean · EG

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundWhen the COVID-19 pandemic was declared, Yemen, a country facing years of conflict had only one laboratory with PCR testing capacity. In this article, we describe the outcome of the implementation of molecular based diagnostics platform in Yemen and highlight the key milestones the country went through to increase access to testing for its populations residing in a geographically vast and politically divided country.

methodsA retrospective assessment of COVID-19 laboratory response activities was done detailing the needs assessment process, timelines, geographical coverage, and outcomes of the activities. Laboratory data was analyzed to construct the geographical locations of COVID-19 testing laboratories and the numbers of tests performed in each facility to highlight the demands of testing for travelers. Finally, we discuss the impact these activities had in enabling the movement of people across international borders for economic gains and in delivery of critical humanitarian aid. OUTCOME: PCR testing capacities in Yemen significantly improved, from one laboratory in Sanaa in April 2020 to 18 facilities across the country by June 2022. In addition, the number of functional Real-Time PCR thermocyclers increased from one to 32, the PCR tests output per day improved from 192 to 6144 tests per day. Results from analysis of laboratory data showed there were four peaks of COVID-19 in Yemen as October 2022. The majority of laboratory tests were performed for travelers than for medical or public health reasons. Demand for laboratory testing in Yemen was generally low and waned over time as the perceived risk of COVID-19 declined, in parallel with rollout of the COVID-19 vaccines. DISCUSSION/

conclusionThe successful expansion of laboratory testing capacity was instrumental in the control and management of COVID-19 cases and critical in the implementation of public response strategies, including restrictions on gathering. Laboratory testing also facilitated the movement of humanitarian agencies and delivery of aid and enabled hundreds of thousands of Yemeni nationals to travel internationally. By virtue of these outcomes, the impact of laboratory strengthening activities was thus felt in the health sector and beyond.

Indexed as

COVID-19COVID-19 TestingCOVID-19 VaccinesDisease OutbreaksEmergenciesHumansLaboratoriesPandemicsPolymerase Chain ReactionRetrospective StudiesYemenCOVID-19 Vaccines

Identifiers

PMID38394178
PMCPMC10889613
OpenAlexW4392122508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.